January 30, 2019
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic&...
Read More
January 30, 2019
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) as Mono...
Read More
January 30, 2019
A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With&h...
Read More
December 10, 2018
Ph II Cabazitaxel DD Liposarcoma
Read More